SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017552
Filing Date
2019-05-09
Accepted
2019-05-09 06:56:07
Documents
51
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q_Q1 2019 reta-10q_20190331.htm 10-Q 1318966
2 EX-10.1 reta-ex101_418.htm EX-10.1 141974
3 EX-10.2 reta-ex102_419.htm EX-10.2 58134
4 EX-10.3 reta-ex103_420.htm EX-10.3 21463
5 EX-31.1 reta-ex311_9.htm EX-31.1 20534
6 EX-31.2 reta-ex312_7.htm EX-31.2 20600
7 EX-32.1 reta-ex321_8.htm EX-32.1 10186
8 EX-32.2 reta-ex322_6.htm EX-32.2 10166
  Complete submission text file 0001564590-19-017552.txt   3639854

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT reta-20190331.xml EX-101.INS 422691
10 XBRL TAXONOMY EXTENSION SCHEMA reta-20190331.xsd EX-101.SCH 30709
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reta-20190331_cal.xml EX-101.CAL 32789
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reta-20190331_def.xml EX-101.DEF 103751
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20190331_lab.xml EX-101.LAB 246069
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20190331_pre.xml EX-101.PRE 180291
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37785 | Film No.: 19808705
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences